CDT EQUITY INC. Public Float
CDT EQUITY INC. (CDT) had Public Float of $55.20 thousand as of 2025-06-30, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-15
- 2025-06-30: Entity Public Float $55.20K.
- 2024-06-28: Entity Public Float $41.40M.
- 2023-06-30: Entity Public Float $23.22M.
- 2022-06-30: Entity Public Float $132.65M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $55.20K 10-K · filed 2026-04-15 |
| 2024-06-28 | $41.40M 10-K · filed 2025-03-28 |
| 2023-06-30 | $23.22M 10-K · filed 2024-04-16 |
| 2022-06-30 | $132.65M 10-K · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |